ELSA-seq / OverC™ Multi-Cancer Detection Blood Test
Multi-Cancer Early Detection (MCED)
Key Facts
Indication
Multi-Cancer Early Detection (MCED)
Phase
Clinical Validation
Status
Active
Company
About Burning Rock Biotech
Burning Rock Biotech is a publicly-traded, commercial-stage diagnostics company specializing in precision oncology. Its core mission is to transform cancer treatment through early detection and personalized therapy selection using advanced genomic profiling. The company has established a significant commercial footprint in China with its portfolio of NGS-based in-vitro diagnostic (IVD) products and laboratory-developed tests (LDTs), while actively developing its multi-cancer early detection (MCED) pipeline. Its strategic direction involves expanding its product portfolio, pursuing regulatory approvals, and exploring international markets.
View full company profileTherapeutic Areas
Other Multi-Cancer Early Detection (MCED) Drugs
| Drug | Company | Phase |
|---|---|---|
| Galleri® Test | GRAIL | Approved/Commercial |
| Early Cancer Detection | Personalis | Research |